EASD e-Learning Platform Relaunch
Our relaunched EASD e-Learning platform offers cutting-edge education for healthcare professionals working on all aspects of diabetes.
our goal is...
...to disseminate knowledge and proficiency in diabetes research and care through education
EASD e-Learning Platform Relaunch
Our relaunched EASD e-Learning platform offers cutting-edge education for healthcare professionals working on all aspects of diabetes.
All our courses are free to access and developed with the world’s leading experts. They include more than 80 CME accredited modules to enhance your professional development.
Whether you are a student or an experienced healthcare professional, we invite you to explore this invaluable resource and to continue your educational journey with the EASD e-Learning platform!
EASD Education
Educational activities have been a core priority of EASD since its foundation and over recent decades have grown in number and geographical range. Our educational portfolio ranges from e-Learning to basic hands-on training courses including workshops to focused meetings on specific topics of diabetes research and care to collaborations with national associations world-wide.
Our aim is to educate, inform and engage healthcare professionals around the world by addressing standard themes in practical diabetology as well as novel and complex themes in modern diabetology that overlap with other medical disciplines.
e-Learning
E-Learning platform to expand the reach of EASD’s educational goal to disseminate knowledge and proficiency in diabetes research and care worldwide.
Meetings and Courses
Focused education meetings and courses, by application or by invitation, on specific topics for small targeted audiences.
Symposia
EASD symposia aiming at enriching local and regional conferences with EASD expertise in diabetes research and care.
Committee
The Training and Education Committee (TEC) has currently 11 members. Each member has an allocated area of expertise.
EASD's educational activities are generously supported by:
Abbott
Amarin
AstraZeneca
Bayer
Boehringer Ingelheim
European Diabetology
Encore
Lilly
Medtronic
MundiPharma
Novartis
Novo Nordisk
Pfizer-MSD Alliance
Roche
Sanofi
Servier